Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

EPT Disclosure - Amendment

25 Jan 2010 11:41

RNS Number : 0635G
Arden Partners plc
25 January 2010
Β 

ο»Ώ

AMENDMENT

FORM 38.5(b)

DEALINGS BYΒ CONNECTED EXEMPT PRINCIPAL TRADERSΒ 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(RuleΒ 38.5(b)Β ofΒ the TakeoverΒ Code)

1. KEY INFORMATION

Name ofΒ exempt principal trader

Arden Partners plc

Company dealt in

Alexandra plc (AXD.L/AXD.PL)

Class of relevant security to which the dealings being disclosed relateΒ (NoteΒ 1)

10p ordinary

Date of dealing

21Β January 2010

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) InterestsΒ and short positionsΒ (following dealing) in the class of relevant security dealt inΒ (NoteΒ 2)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securitiesΒ 

47,607

0.14%

(2) DerivativesΒ (other than options)

(3)Β OptionsΒ and agreements to purchase/sell

Total

47,607

0.14%

(b) Interests and short positions in relevant securities of the company, other than the class dealt inΒ 

(NoteΒ 2)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securitiesΒ 

(2) DerivativesΒ (other than options)

(3)Β OptionsΒ and agreements to purchase/sell

Total

Rights to subscribeΒ (NoteΒ 2)

Class of relevant security:

Details

3. DEALINGSΒ (Note 3)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unitΒ (NoteΒ 4)

Sale

30,000

17.0

(b) Derivatives transactions (other than options)

Product name,Β 

e.g. CFD

Long/shortΒ (NoteΒ 5)

Number of securitiesΒ (NoteΒ 6)

Price per unitΒ (NoteΒ 4)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Β callΒ option

Writing, selling, purchasing, varying etc.

Number of securitiesΒ to which the option relatesΒ (NoteΒ 6)

Exercise

priceΒ 

Type, e.g. American, European etc.

ExpiryΒ 

date

Option money

paid/receivedΒ per unitΒ (NoteΒ 4)Β 

(ii) Exercising

Product name, e.g.Β call option

Number of securitiesΒ 

Exercise priceΒ per unitΒ (NoteΒ 4)

(d) Other dealings (including new securities)Β (NoteΒ 3)

Nature of transactionΒ (NoteΒ 7)

Details

Price per unitΒ (if applicable)Β (NoteΒ 4)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form orΒ relating to the voting rights orΒ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached?Β (Note 8)

NO

Date of disclosure

25Β January 2010

Contact name

Stephen Cooper

Telephone number

Direct dial - 020 7614Β 5936

Mob - 07780 678 645

Name of offeree/offeror with which connected

Not known

NatureΒ of connectionΒ (NoteΒ 9)

Broker

Notes

The Notes on FormΒ 38.5(b)Β can be viewed on the Takeover Panel's websiteΒ atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
EMMLLFSLLIIEFII
Date   Source Headline
22nd Jan 201011:17 amRNSEPT Disclosure
20th Jan 201010:46 amRNSEPT Disclosure
11th Jan 201011:32 amRNSEPT Disclosure
7th Jan 201011:53 amRNSEPT Disclosure
5th Jan 201011:01 amRNSEPT Disclosure
4th Jan 201011:24 amRNSEPT Disclosure
31st Dec 200910:04 amRNSEPT Disclosure
23rd Dec 200911:46 amRNSEPT Disclosure
22nd Dec 200911:09 amRNSEPT Disclosure
21st Dec 200911:46 amRNSEPT Disclosure
18th Dec 20093:59 pmRNSEPT Disclosure
11th Dec 200911:30 amRNSEPT Disclosure
26th Nov 200911:59 amRNSEPT Disclosure
25th Nov 200911:40 amRNSEPT Disclosure
23rd Nov 200910:07 amRNSBlocklisting Return
16th Nov 200910:29 amRNSEPT Disclosure
2nd Nov 200911:38 amRNSTotal Voting Rights
14th Sep 20094:08 pmRNSEBT purchase
4th Sep 200911:20 amRNSEPT Disclosure
1st Sep 20091:59 pmRNSTotal Voting Rights
1st Sep 200910:31 amRNSEPT Disclosure
25th Aug 200910:01 amRNSEPT Disclosure
20th Aug 200911:23 amRNSEPT Disclosure
19th Aug 200911:29 amRNSEPT Disclosure
18th Aug 200910:24 amRNSEPT Disclosure
14th Aug 200910:21 amRNSEPT Disclosure
13th Aug 200911:28 amRNSEPT Disclosure
11th Aug 200911:41 amRNSEPT Disclosure - Amendment
11th Aug 200911:24 amRNSEPT Disclosure
10th Aug 20099:47 amRNSEPT Disclosure
6th Aug 20099:47 amRNSEPT Disclosure
5th Aug 200910:48 amRNSEPT Disclosure
31st Jul 20099:29 amRNSEPT Disclosure
30th Jul 200910:45 amRNSEPT Disclosure
24th Jul 20091:16 pmRNSDirector's dealing
24th Jul 200910:08 amRNSEPT Disclosure
23rd Jul 20099:19 amRNSEPT Disclosure
17th Jul 20091:44 pmRNSEBT Purchase
14th Jul 20097:00 amRNSInterim results
10th Jul 200910:08 amRNSEPT Disclosure
9th Jul 20099:56 amRNSEPT Disclosure
3rd Jul 20097:00 amRNSNotice of Results
1st Jul 20099:31 amRNSEPT Disclosure
25th Jun 20099:52 amRNSEPT Disclosure
24th Jun 200911:01 amRNSEPT Disclosure
23rd Jun 200910:17 amRNSEPT Disclosure
15th Jun 200912:13 pmRNSAndrew Heath Appointed Head of Equities
12th Jun 200910:43 amRNSEPT Disclosure
11th Jun 200910:15 amRNSEPT Disclosure
10th Jun 200910:26 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.